NovaBay Pharma Balance Sheet - Quarterly (NYSEMKT:NBY)

Add to My Stocks
$1.4 $0.05 (3.7%) NBY stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at NovaBay Pharma balance sheet. Financial strength can be guaged by performing NovaBay Pharma stock analysis and by analyzing the balance sheet. A company releases its balance sheet every quarter along with its quarterly results. NovaBay Pharma balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of 0.87 and debt to equity ratio of 0. Also check NovaBay Pharma revenue and NovaBay Pharma operating cash flow for the same period.

View and download NovaBay Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash6.83M8.33M3.19M6.07M5.72M7.39M9.51M9.43M3.49M1.43M
Marketable Securities----------
Receivables2.02M2.22M3.62M2.23M3.6M2.33M2.12M2.07M1.49M1.49M
Inventory-------1.08M1.11M1.2M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.6M1.75M1.66M1.03M-1.03M1.96M1.82M--
Total Current Assets
10.77M12.79M8.99M9.93M10.96M11.53M14.47M14.42M6.57M4.56M
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
11.71M13.82M10.07M11.05M12.07M12.68M15.38M15.14M7M4.93M
Notes Payable----------
Accounts Payable---------1.82M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses2.67M2.85M1.67M2.41M1.65M1.83M1.8M1.88M1.91M2.01M
Income Taxes Payable----------
Other Current Liabilities--2.84M2.48M2.17M1.67M2.06M1.46M1.59M-
Total Current Liabilities
3.06M3.21M4.97M5.26M4.73M4.3M4.32M3.72M4.36M4.02M
Mortgages----------
Deferred Taxes/Income---1.85M2.29M2.12M2.31M2.16M2.32M3.3M
Convertible Debt----------
Long-Term Debt---------3.06M
Non-Current Capital Leases----------
Other Long-Term Liabilities-1.47M1.7M2.1M1.82M1.9M1.64M2.53M2.25M1.83M
Total Liabilities
4.28M4.95M7.48M9.22M8.86M8.32M8.28M8.42M9.47M12.23M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus119.43M119.28M113.51M113.54M112.47M111.88M110.61M108.59M95.72M88.24M
Retained Earnings-112.18M-110.58M-111.07M-111.86M-109.42M-107.68M-103.67M-102.02M-98.28M-95.59M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity7.43M8.87M2.59M1.83M3.2M4.35M7.1M6.71M-2.46M-7.29M
Total Liabilities & Shareholders Equity11.71M13.82M10.07M11.05M12.07M12.68M15.38M15.14M7M4.93M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest NovaBay Pharma stock price, and NovaBay Pharma historical stock prices show the stock price movement over time, and the NovaBay Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like NovaBay Pharma owns and has monetary significance. NBY assets decreased from $13.82M in 2018 Q1 to $11.71M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case NovaBay Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for NBY stock stand at $4.28M.

NovaBay Pharma Balance Sheet - Key Ratios

Current ratio
3.52
Debt to equity ratio
0
Asset turnover ratio
0.87
Receivables turnover
5.9
Price to book ratio
5